Int J Impot Res:派罗尼病患者对健康信息和治疗方法选择的长期评估

2018-05-30 AlexYang MedSci原创

尽管派罗尼病(PD)治疗的选择各种各样,但是文献在患者倾向选择治疗方法方面却鲜有研究。最近,有研究人员探索了PD男性在诊断后对资源和治疗方法做出的选择情况。研究人员给719名随机选择的PD男性发送了相关调查,这些男性在1990年到2012年在研究人员所在单位进行了评估。调查的问题包括治疗方法的评估和更加倾向性的信息资源。结果利用描述性的报告呈现,并加以统计分析。研究总共包括了162名对调查回应的男

尽管派罗尼病(PD)治疗的选择各种各样,但是文献在患者倾向选择治疗方法方面却鲜有研究。最近,有研究人员探索了PD男性在诊断后对资源和治疗方法做出的选择情况。

研究人员给719名随机选择的PD男性发送了相关调查,这些男性在1990年到2012年在研究人员所在单位进行了评估。调查的问题包括治疗方法的评估和更加倾向性的信息资源。结果利用描述性的报告呈现,并加以统计分析。研究总共包括了162名对调查回应的男性(平均年龄65岁),他们的平均PD时间为9.2年。信息资源包括医疗网站(38.9%)、医生(35.8%)和书籍(<1%)。总之,患者认为72.5%的医生对PD具有很好的理解。大约53.1%的男性尝试了至少一种治疗方法,37.2%的男性尝试了2种或者更多的方法。在比较治疗中,大多数外科手术患者报道具有改善(82.8%)。另外,在一个PD男性群体中,医疗网站是最为常用的信息来源。几乎接近一半的患者选择不再进行任何形式的治疗,然而剩余的大多数选择非手术性干预。

最后,研究人员指出,他们的结果表明了更大的耐心和PD治疗知识教育都是需要的。

原始出处:

Raevti Bole, Matthew Ziegelmann, Ross Avant et al. Patient's choice of health information and treatment modality for Peyronie's disease: a long-term assessment. Int J Impot Res. 25 May 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2069391, encodeId=4e00206939116, content=<a href='/topic/show?id=82ac2e7483c' target=_blank style='color:#2F92EE;'>#健康信息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27748, encryptionId=82ac2e7483c, topicName=健康信息)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Mon Apr 22 18:44:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399248, encodeId=24e913992485b, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575078, encodeId=101c15e507892, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2069391, encodeId=4e00206939116, content=<a href='/topic/show?id=82ac2e7483c' target=_blank style='color:#2F92EE;'>#健康信息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27748, encryptionId=82ac2e7483c, topicName=健康信息)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Mon Apr 22 18:44:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399248, encodeId=24e913992485b, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575078, encodeId=101c15e507892, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2069391, encodeId=4e00206939116, content=<a href='/topic/show?id=82ac2e7483c' target=_blank style='color:#2F92EE;'>#健康信息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27748, encryptionId=82ac2e7483c, topicName=健康信息)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Mon Apr 22 18:44:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399248, encodeId=24e913992485b, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575078, encodeId=101c15e507892, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Fri Jun 01 10:44:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-01 风铃826